{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T20:42:09Z","timestamp":1784925729420,"version":"3.55.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","award":["503\/1-155-02\/503-11-003-20"],"award-info":[{"award-number":["503\/1-155-02\/503-11-003-20"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","award":["502-03\/1-155-02\/502-14-386-18"],"award-info":[{"award-number":["502-03\/1-155-02\/502-14-386-18"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.clnesp.2024.07.1024","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T17:20:00Z","timestamp":1722360000000},"page":"604-614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Probiotics may be useful for drug-induced liver dysfunction in patients with depression \u2013 A secondary analysis of a randomized clinical trial"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1398-3117","authenticated-orcid":false,"given":"Oliwia","family":"Gawlik-Kotelnicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Burzy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Rogalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Skowro\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Strzelecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2024.07.1024_bib1","article-title":"A\u00a0multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2023","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib3","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib4","first-page":"1","article-title":"Co-morbidities of mental disorders and chronic physical diseases in developing and emerging countries: a meta-analysis","volume":"19","author":"Dar\u00e9","year":"2019","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jad.2020.01.141","article-title":"Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990\u20132019: systematic review and meta-analysis","volume":"266","author":"Hunt","year":"2020","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00406-022-01380-1","article-title":"Affective lability and social functioning in severe mental disorders","volume":"272","author":"H\u00f8egh","year":"2022","journal-title":"Eur Arch Psychiatr Clin Neurosci"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib7","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.3390\/ijerph18105227","article-title":"Non-alcoholic fatty liver disease: metabolic, genetic, epigenetic and Environmental risk factors","volume":"18","author":"Juanola","year":"2021","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-3-030-28737-5_14","article-title":"The disappearing microbiota: diseases of the Western civilization","author":"Salvucci","year":"2019","journal-title":"How Fermented Foods Feed a Healthy Gut Microbiota: A Nutrition Continuum, Springer International Publishing"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib9","article-title":"Gut microbiota\u2013brain axis in depression: the role of neuroinflammation","author":"Carlessi","year":"2019","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib10","article-title":"Analysis of gut microbiota and intestinal integrity markers of inpatients with major depressive disorder","author":"Li\u015bkiewicz","year":"2020","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2020.01.102","article-title":"Gut microbiota and majore depressive disorder: a systematic review and meta-analysis","volume":"266","author":"Sanada","year":"2020","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jad.2020.01.137","article-title":"Reduced anti-inflammatory gut microbiota are associated with depression and anhedonia","volume":"266","author":"Mason","year":"2020","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jad.2019.12.020","article-title":"The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness","volume":"264","author":"Madan","year":"2020","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib15","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3390\/cimb46020078","article-title":"Gut\u2013liver Axis as a therapeutic target for drug-induced liver injury","volume":"46","author":"Tao","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/nu8080483","article-title":"Effect of probiotics on depression: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Huang","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112568","article-title":"Effect of probiotics on depressive symptoms: a meta-analysis of human studies","volume":"282","author":"Goh","year":"2019","journal-title":"Psychiatr Res"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neubiorev.2019.03.023","article-title":"Prebiotics and probiotics for depression and anxiety: a systematic review and meta-analysis of controlled clinical trials","volume":"102","author":"Liu","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jad.2017.11.063","article-title":"A\u00a0meta-analysis of the use of probiotics to alleviate depressive symptoms","volume":"228","author":"Ng","year":"2018","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib20","first-page":"647","article-title":"Updated review and meta-analysis of probiotics for the treatment of clinical depression: adjunctive vs. Stand-alone treatment","volume":"10","author":"Nikolova","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094494","article-title":"The gut microbiome in depression and potential benefit of prebiotics, probiotics and Synbiotics: a systematic review of clinical trials and Observational studies","volume":"23","author":"Alli","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/nu14030621","article-title":"Effect of probiotics on psychiatric symptoms and central nervous system functions in human health and disease: a systematic review and meta-analysis","volume":"14","author":"Le Morvan de Sequeira","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib23","article-title":"Impact of probiotics and prebiotics targeting metabolic syndrome","volume":"64","author":"Xavier-Santos","year":"2020","journal-title":"J\u00a0Funct Foods"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib24","article-title":"Effect of probiotics therapy on nonalcoholic fatty liver disease","volume":"2022","author":"Huang","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1155306","article-title":"Effects of probiotics on non-alcoholic fatty liver disease: a review of human clinical trials","volume":"10","author":"Cao","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ph14040384","article-title":"Probiotics as a treatment for \u201cmetabolic depression\u201d? A rationale for future studies","volume":"14","author":"Gawlik-Kotelnicka","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib27","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/nu16091389","article-title":"Metabolic status influences probiotic efficacy for depression\u2014PRO-DEMET randomized clinical trial results","volume":"16","author":"Gawlik-Kotelnicka","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib28","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib29","first-page":"1342","article-title":"The influence of probiotic supplementation on depressive symptoms, inflammation, and oxidative stress parameters and fecal microbiota in patients with depression depending on metabolic syndrome comorbidity\u2014PRO-DEMET randomized study protocol","volume":"10","author":"Gawlik-Kotelnicka","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib31","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cgh.2016.03.034","article-title":"Development and validation of the Framingham steatosis index to identify persons with hepatic steatosis","volume":"14","author":"Long","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1163052","article-title":"Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study","volume":"10","author":"Cho","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib33","series-title":"Clinical biochemistry and hematology. The laboratory rabbit, Guinea pig, hamster, and other rodents","first-page":"57","author":"Washington","year":"2012"},{"issue":"1","key":"10.1016\/j.clnesp.2024.07.1024_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-94277-3","article-title":"AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects","volume":"11","author":"De Matteis","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib35","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib36","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeac030","article-title":"High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general population","volume":"2","author":"Higashiura","year":"2022","journal-title":"European Heart Journal Open"},{"issue":"1","key":"10.1016\/j.clnesp.2024.07.1024_bib38","first-page":"27","article-title":"\u201cValidation of food frequency questionnaire (FFQ). Reproducibility assessment\u201d Bromat","volume":"38","author":"W\u0105do\u0142owska","year":"2005","journal-title":"Chem. Toksykol"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib39","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A\u00a0new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0005-7967(96)00068-X","article-title":"Psychometric properties of the depression anxiety stress scales (DASS) in clinical samples","volume":"35","author":"Brown","year":"1997","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/B:QURE.0000018486.91360.00","article-title":"The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial a Report from the WHOQOL Group","volume":"13","author":"Skevington","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-2-8","article-title":"Do multiple outcome measures require p-value adjustment?","volume":"2","author":"Feise","year":"2002","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100648","article-title":"New approaches to triglyceride reduction: is there any hope left?","volume":"18","author":"Filtz","year":"2024","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017995","article-title":"Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials","volume":"9","author":"Koutnikova","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1484598","article-title":"Systematic review with meta-analysis: the effects of probiotics in nonalcoholic fatty liver disease","volume":"2019","author":"Xiao","year":"2019","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819878046","article-title":"Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"12","author":"Tang","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib47","article-title":"Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"10","author":"Pan","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib48","article-title":"The effect of probiotics (MCP\u00ae BCMC\u00ae strains) on hepatic steatosis, small intestinal mucosal immune function, and intestinal barrier in patients with non-alcoholic fatty liver disease","volume":"13","author":"Nor","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib49","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1053\/j.gastro.2020.01.031","article-title":"Investigation of synbiotic treatment in non-alcoholic fatty liver disease (INSYTE study): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"158","author":"Scorletti","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib50","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2223339","article-title":"Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis","volume":"15","author":"G\u00f3mez-P\u00e9rez","year":"2023","journal-title":"Gut Microb"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib51","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.clnu.2024.04.004","article-title":"Optimal probiotic combinations for treating nonalcoholic fatty liver disease: a systematic review and network meta-analysis","volume":"43","author":"Yang","year":"2024","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdnut.2024.102083","article-title":"Bacillus coagulans TCI711 supplementation improved nonalcoholic fatty liver by modulating gut microbiota: a randomized, placebo-controlled, clinical trial","volume":"8","author":"Hsieh","year":"2024","journal-title":"Curr Dev Nutr"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib53","doi-asserted-by":"crossref","first-page":"15518","DOI":"10.3748\/wjg.v20.i42.15518","article-title":"Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease","volume":"20","author":"Paolella","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1334935","article-title":"Probiotic consumption and hepatic steatosis: results from the NHANES 2011-2016 and Mendelian randomization study","volume":"11","author":"Song","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ph14040384","article-title":"Probiotics as a treatment for \u201cmetabolic depression\u201d? A rationale for future studies","volume":"14","author":"Gawlik-Kotelnicka","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1370658","article-title":"Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases","volume":"15","author":"Niu","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib57","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/antiox13030329","article-title":"Roles of traditional and next-generation probiotics on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a systematic review and network meta-analysis","volume":"13","author":"Zhu","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib58","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury \u2014 types and phenotypes","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib59","series-title":"Antidepressant-induced liver injury: a review for clinicians","first-page":"404","author":"Voican","year":"2014"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib60","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/acps.13310","article-title":"Metabolomic profiles discriminating anxiety from depression","volume":"144","author":"de Kluiver","year":"2021","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/life11020117","article-title":"Adiposity in depression or depression in adiposity? The role of immune-inflammatory-microbial overlap","volume":"11","author":"Gawlik-Kotelnicka","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.711835","article-title":"Interaction mechanisms between major depressive disorder and non-alcoholic fatty liver disease","volume":"12","author":"Shao","year":"2021","journal-title":"Front Psychiatr"},{"issue":"7","key":"10.1016\/j.clnesp.2024.07.1024_bib63","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib64","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.cgh.2021.12.034","article-title":"Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population","volume":"20","author":"Graupera","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib65","article-title":"FIB-4 index associated with mortality risk of patients with systemic lupus erythematosus: a large retrospective cohort study","author":"Sun","year":"2020","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib66","series-title":"FIB-4 first in the diagnostic algorithm of metabolic-dysfunction-associated fatty liver disease in the era of the global metabodemic. Life","first-page":"1","author":"Sumida","year":"2021"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib67","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-022-02290-1","article-title":"Distribution of FIB-4 index in the general population: analysis of 75,666 residents who underwent health checkups","volume":"22","author":"Sugiyama","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib68","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Prophylactic supplementation with Lactobacillus reuteri or its metabolite GABA protects against acute ischemic cardiac injury","author":"Wang","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib69","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib70","article-title":"Stress, inflammation, microbiome and depression","volume":"173561","author":"Medina-Rodriguez","year":"2023","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/biom12010056","article-title":"Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and Perspectives","volume":"12","author":"Vallianou","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib72","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/MEG.0000000000002377","article-title":"An elevated FIB-4 score is not associated with cardiovascular events: a longitudinal analysis from 137 842 patients with and without chronic liver disease","volume":"34","author":"Loosen","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1172178","article-title":"Association between FIB-4, all-cause mortality, cardiovascular mortality, and cardiovascular disease risk among diabetic individuals: NHANES 1999-2008","volume":"10","author":"Guan","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94277-3","article-title":"AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects","volume":"11","author":"De Matteis","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2024.07.1024_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/nu12020381","article-title":"Role of dietary nutrients in the modulation of gut microbiota: a narrative review","volume":"12","author":"Yang","year":"2020","journal-title":"Nutrients"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724012300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724012300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T04:22:52Z","timestamp":1737346972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457724012300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":75,"alternative-id":["S2405457724012300"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.07.1024","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probiotics may be useful for drug-induced liver dysfunction in patients with depression \u2013 A secondary analysis of a randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.07.1024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}]}}